SRPT logo

Sarepta Therapeutics (SRPT) Long term debt

Annual long term debt:

$1.33B+$56.12M(+4.41%)
December 31, 2024

Summary

  • As of today (May 29, 2025), SRPT annual long term debt is $1.33 billion, with the most recent change of +$56.12 million (+4.41%) on December 31, 2024.
  • During the last 3 years, SRPT annual long term debt has risen by +$191.21 million (+16.80%).
  • SRPT annual long term debt is now -17.00% below its all-time high of $1.60 billion, reached on December 31, 2022.

Performance

SRPT Long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTbalance sheet metrics

Quarterly long term debt:

$1.34B+$14.15M(+1.06%)
March 1, 2025

Summary

  • As of today (May 29, 2025), SRPT quarterly long term debt is $1.34 billion, with the most recent change of +$14.15 million (+1.06%) on March 1, 2025.
  • Over the past year, SRPT quarterly long term debt has increased by +$69.99 million (+5.49%).
  • SRPT quarterly long term debt is now -16.11% below its all-time high of $1.60 billion, reached on December 31, 2022.

Performance

SRPT Quarterly long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTbalance sheet metrics

Long term debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

SRPT Long term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+4.4%+5.5%
3 y3 years+16.8%+18.1%
5 y5 years+82.2%+78.4%

SRPT Long term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-17.0%+16.8%-16.1%+18.1%
5 y5-year-17.0%+82.2%-16.1%+78.4%
alltimeall time-17.0%>+9999.0%-16.1%>+9999.0%

SRPT Long term debt History

DateAnnualQuarterly
Mar 2025
-
$1.34B(+1.1%)
Dec 2024
$1.33B(+4.4%)
$1.33B(+1.8%)
Sep 2024
-
$1.31B(+2.2%)
Jun 2024
-
$1.28B(+0.4%)
Mar 2024
-
$1.27B(+0.0%)
Dec 2023
$1.27B(-20.5%)
$1.27B(-7.1%)
Sep 2023
-
$1.37B(+0.5%)
Jun 2023
-
$1.36B(+5.9%)
Mar 2023
-
$1.29B(-19.6%)
Dec 2022
$1.60B(+40.7%)
$1.60B(+1.5%)
Sep 2022
-
$1.58B(+38.4%)
Jun 2022
-
$1.14B(+0.2%)
Mar 2022
-
$1.14B(-0.1%)
Dec 2021
$1.14B(+6.1%)
$1.14B(-1.7%)
Sep 2021
-
$1.16B(+0.0%)
Jun 2021
-
$1.16B(+0.6%)
Mar 2021
-
$1.15B(+7.4%)
Dec 2020
$1.07B(+47.0%)
$1.07B(+39.6%)
Sep 2020
-
$768.70M(+0.3%)
Jun 2020
-
$766.56M(+1.8%)
Mar 2020
-
$753.22M(+3.2%)
Dec 2019
$729.62M(+73.5%)
$729.62M(+50.1%)
Sep 2019
-
$486.16M(+1.0%)
Jun 2019
-
$481.25M(+0.7%)
Mar 2019
-
$477.92M(+13.6%)
Dec 2018
$420.55M(-1.0%)
$420.55M(+1.2%)
Sep 2018
-
$415.45M(-3.4%)
Jun 2018
-
$429.93M(+0.6%)
Mar 2018
-
$427.37M(+0.6%)
Dec 2017
$424.88M(+6932.0%)
$424.88M(+1500.3%)
Sep 2017
-
$26.55M(+1033.2%)
Mar 2017
-
$2.34M(-61.2%)
Dec 2016
$6.04M
$6.04M(-28.8%)
Sep 2016
-
$8.49M(-16.0%)
Jun 2016
-
$10.11M(-24.4%)
DateAnnualQuarterly
Mar 2016
-
$13.37M(-10.7%)
Dec 2015
$14.97M(+300.5%)
$14.97M(-14.0%)
Sep 2015
-
$17.40M(-15.8%)
Jun 2015
-
$20.65M(+1324.3%)
Mar 2015
-
$1.45M(-61.2%)
Dec 2014
$3.74M(+137.2%)
$3.74M(-0.7%)
Sep 2014
-
$3.76M(+146.8%)
Jun 2014
-
$1.52M(-1.7%)
Mar 2014
-
$1.55M(-1.6%)
Dec 2013
$1.58M(-5.5%)
$1.58M(-1.4%)
Sep 2013
-
$1.60M(-1.4%)
Jun 2013
-
$1.62M(-1.4%)
Mar 2013
-
$1.65M(-1.4%)
Dec 2012
$1.67M(-5.1%)
$1.67M(-1.3%)
Sep 2012
-
$1.69M(-1.3%)
Jun 2012
-
$1.71M(-1.3%)
Mar 2012
-
$1.74M(-1.3%)
Dec 2011
$1.76M(-4.6%)
$1.76M(-1.2%)
Sep 2011
-
$1.78M(-1.2%)
Jun 2011
-
$1.80M(-1.2%)
Mar 2011
-
$1.82M(-1.1%)
Dec 2010
$1.84M(-4.3%)
$1.84M(-1.1%)
Sep 2010
-
$1.86M(-1.1%)
Jun 2010
-
$1.88M(-37.5%)
Mar 2010
-
$3.01M(+56.5%)
Dec 2009
$1.92M(-23.5%)
$1.92M(-1.3%)
Sep 2009
-
$1.95M(-23.3%)
Jun 2009
-
$2.54M(+1.2%)
Mar 2009
-
$2.51M(-0.2%)
Dec 2008
$2.52M(+21.5%)
$2.52M(+24.9%)
Sep 2008
-
$2.02M(-0.9%)
Jun 2008
-
$2.03M(-3.1%)
Mar 2008
-
$2.10M(+1.3%)
Dec 2007
$2.07M
$2.07M(-0.9%)
Sep 2007
-
$2.09M(-0.8%)
Jun 2007
-
$2.11M

FAQ

  • What is Sarepta Therapeutics annual long term debt?
  • What is the all time high annual long term debt for Sarepta Therapeutics?
  • What is Sarepta Therapeutics annual long term debt year-on-year change?
  • What is Sarepta Therapeutics quarterly long term debt?
  • What is the all time high quarterly long term debt for Sarepta Therapeutics?
  • What is Sarepta Therapeutics quarterly long term debt year-on-year change?

What is Sarepta Therapeutics annual long term debt?

The current annual long term debt of SRPT is $1.33B

What is the all time high annual long term debt for Sarepta Therapeutics?

Sarepta Therapeutics all-time high annual long term debt is $1.60B

What is Sarepta Therapeutics annual long term debt year-on-year change?

Over the past year, SRPT annual long term debt has changed by +$56.12M (+4.41%)

What is Sarepta Therapeutics quarterly long term debt?

The current quarterly long term debt of SRPT is $1.34B

What is the all time high quarterly long term debt for Sarepta Therapeutics?

Sarepta Therapeutics all-time high quarterly long term debt is $1.60B

What is Sarepta Therapeutics quarterly long term debt year-on-year change?

Over the past year, SRPT quarterly long term debt has changed by +$69.99M (+5.49%)
On this page